Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

DHT stops hair regrowth in mice, similar to human hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain gene variations might be linked to severe acne in women but not in men.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Blocking testosterone speeds up wound healing in males.

Blocking testosterone speeds up wound healing in males.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Minoxidil can reduce functions related to androgen receptors.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.